Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivosimab combined with chemotherapy for resectable colorectal cancer liver metastases
NCT06972498Phase 2Not yet recruiting
- Sponsor
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jul 2025
- Primary completion
- Dec 2027
- Modality
- Antibody Conjugates, Bispecific Antibodies, Monoclonal Antibodies
01
Overview
A Phase 2 trial of ivonescimab in colorectal cancer (CRC), sponsored by The Fourth Affiliated Hospital of Zhejiang University School of Medicine. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
ivonescimab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06972498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06972498.